Konrad Nowak

Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy et al. · The Lancet · 2024 · 101 citations · Full text

Thrombosis, Superiority Trial, Ischemic Stroke +12

GRACE, TIMI, Zwolle and CADILLAC risk scores — Do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively?

Anna Kozieradzka, Karol Kamiński, Dominika Maciorkowska et al. · International Journal of Cardiology · 2009 · 66 citations

Percutaneous Coronary Intervention, Health Policy, Cardiovascular Disease +14

Takotsubo cardiomyopathy: serious early complications and two-year mortality – a 101 case study

Małgorzata Zalewska-Adamiec, Hanna Bachórzewska-Gajewska, Anna Tomaszuk−Kazberuk et al. · Netherlands Heart Journal · 2016 · 44 citations · Full text

Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction

Karol Kamiński, Marcin Kożuch, Tomasz A. Bonda et al. · Atherosclerosis · 2009 · 32 citations

Inflammation, Cardiovascular Disease, Soluble Receptors +9

Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals

Sławomir Dobrzycki, Paweł Kralisz, Konrad Nowak et al. · European Heart Journal · 2007 · 29 citations · Full text